Literature DB >> 8605695

Immune dysfunction in Down's syndrome: primary immune deficiency or early senescence of the immune system?

E Cuadrado1, M J Barrena.   

Abstract

Multiple immunologic disturbances are commonly observed in individuals with Down's syndrome including abnormal proportions of peripheral blood lymphoid subsets, cellular dysfunction, and autoimmune phenomena. However, a majority of the individuals with this syndrome do not show clear features of immunological disease. Many of these immunological alterations are age-related changes and can be enclosed in the spectrum of multiple signs of early senescence characteristic of Down's syndrome.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8605695     DOI: 10.1006/clin.1996.0031

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  33 in total

1.  Down syndrome: is it really characterized by precocious immunosenescence?

Authors:  Maaike Aa Kusters; Ruud Hj Verstegen; Esther de Vries
Journal:  Aging Dis       Date:  2011-12-02       Impact factor: 6.745

Review 2.  Replicative senescence in the immune system: impact of the Hayflick limit on T-cell function in the elderly.

Authors:  R B Effros
Journal:  Am J Hum Genet       Date:  1998-05       Impact factor: 11.025

3.  Tumorigenesis in Down's syndrome: big lessons from a small chromosome.

Authors:  Dean Nižetić; Jürgen Groet
Journal:  Nat Rev Cancer       Date:  2012-09-21       Impact factor: 60.716

Review 4.  Infections and immunodeficiency in Down syndrome.

Authors:  G Ram; J Chinen
Journal:  Clin Exp Immunol       Date:  2011-02-24       Impact factor: 4.330

5.  High positivity of anti-CCP antibodies in patients with Down syndrome.

Authors:  Renato M Nisihara; Thelma L Skare; Marília B G Silva; Iara T Messias-Reason; Nanci P Oliveira; Patricia T Fiedler; Shirley R R Utiyama
Journal:  Clin Rheumatol       Date:  2007-03-27       Impact factor: 2.980

6.  Lack of age-associated LFA-1 up-regulation and impaired ICAM-1 binding in lymphocytes from patients with Down syndrome.

Authors:  S J Lin; J Y Wang; L B Klickstein; K P Chuang; J Y Chen; J F Lee; C C Shieh
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

7.  Diabetic ketoacidosis, thyroiditis and alopecia areata in a child with Down syndrome.

Authors:  Ozgur Pirgon; Mehmet Emre Atabek; Ahmet Sert
Journal:  Indian J Pediatr       Date:  2009-12-11       Impact factor: 1.967

8.  Maternal health conditions during pregnancy and acute leukemia in children with Down syndrome: A Children's Oncology Group study.

Authors:  Simona Ognjanovic; Susan Puumala; Logan G Spector; Franklin O Smith; Leslie L Robison; Andrew F Olshan; Julie A Ross
Journal:  Pediatr Blood Cancer       Date:  2009-05       Impact factor: 3.167

Review 9.  Cellular and molecular basis of immunodeficiencies: their consequences for the development and induction of the immune response.

Authors:  J Sterzl
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

10.  Down syndrome, autoimmunity and T regulatory cells.

Authors:  F P Pellegrini; M Marinoni; V Frangione; A Tedeschi; V Gandini; F Ciglia; L Mortara; R S Accolla; L Nespoli
Journal:  Clin Exp Immunol       Date:  2012-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.